-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IwedC8/Ed075mSKhptjCt+L4rOXQ0cs47tm7bEeiWtDcUM4GnqTE+SB1EYYqodh3 fCfRv066frkh/tw8MI1gaA== 0001144204-07-066048.txt : 20071205 0001144204-07-066048.hdr.sgml : 20071205 20071205215212 ACCESSION NUMBER: 0001144204-07-066048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071203 FILED AS OF DATE: 20071205 DATE AS OF CHANGE: 20071205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARDINER SANDRA CENTRAL INDEX KEY: 0001218574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 071288035 BUSINESS ADDRESS: STREET 1: C/O LIPID SCIENCES INC STREET 2: 7068 KOLL CENTR PARKWAY STE 401 CITY: PLEASANTON STATE: GA ZIP: 94566 BUSINESS PHONE: 9252494025 MAIL ADDRESS: STREET 1: C/O LIPID SCIENCES INC STREET 2: 7068 KOLL CENTER PARKWAY STE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 4 1 v096418_ex.xml X0202 4 2007-12-03 0 0000071478 LIPID SCIENCES INC/ LIPD 0001218574 GARDINER SANDRA 7068 KOLL CENTER PARKWAY STE 401 PLEASANTON CA 94566 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.21 2007-12-03 4 D 0 77951 D 2011-01-31 Common Stock 77951 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 77951 D 2011-01-31 Common Stock 77951 77951 D Stock Option (right to buy) 3.70 2007-12-03 4 D 0 34744 D 2015-03-09 Common Stock 34744 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 34744 D 2015-03-09 Common Stock 34744 34744 D Stock Option (right to buy) 2.64 2007-12-03 4 D 0 27305 D 2016-02-27 Common Stock 27305 0 D Stock Option (right to buy) 0.89 2007-12-03 4 A 0 27305 D 2016-02-27 Common Stock 27305 27305 D The six reported transactions involved an amendment of three outstanding options, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The options were originally granted on February 1, 2001, March 10, 2005 and February 28, 2006. The options vested in equal installments on each monthly anniversary of the grant date over a period of 48 months. The option fully vested on February 28, 2006 in connection with approval by the Federal Drug Administration of the Company's Investigational Device Exemption relating to HDL Selective Delipidation. The option with respect to 1/3rd of the shares vests in equal installments on the 1st, 2nd and 3rd annual anniversaries of the grant date. /s/Sandra Gardiner 2007-12-05 -----END PRIVACY-ENHANCED MESSAGE-----